Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D00QKS
|
|||
| Former ID |
DIB002727
|
|||
| Drug Name |
BMS-954561
|
|||
| Synonyms |
AGN-001; AGN-209323; AGN-2XXXXX; AGN-323; EHT-001; EHT/AGN-0001; EHT/AGN-001; GABA/nicotinic modulator (neuroscience), BMS; Neuropathic pain therapy, ExonHit/Allergan/Bristol-Myers Squibb
Click to Show/Hide
|
|||
| Indication | Diabetic neuropathy [ICD-11: 8C0Z; ICD-10: G63, G63.2] | Phase 2 | [1] | |
| Company |
Exonhit
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Nicotinic acetylcholine receptor (nAChR) | Target Info | Modulator | [2] |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT01314222) Diabetic Peripheral Neuropathic Pain (DPNP). U.S. National Institutes of Health. | |||
| REF 2 | EP patent application no. 2774991, Drug delivery system for use in the treatment or diagnosis of neurological disorders. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.